C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2002
10/24/2002	WO2002083736A2 G-protein coupled receptor molecules and uses thereof
10/24/2002	WO2002083727A2 Nucleic acid sequences of hyperplasies and tumors of the thyroid
10/24/2002	WO2002083721A1 Protein cluster v
10/24/2002	WO2002083720A2 Intermediates and enzymes of the non-mevalonate isoprenoid pathway
10/24/2002	WO2002083712A2 Transporters and ion channels
10/24/2002	WO2002083711A2 Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies
10/24/2002	WO2002083709A2 Kinases and phosphatases
10/24/2002	WO2002083707A1 Tub antisense constructs
10/24/2002	WO2002083704A1 Vascular endothelial growth factor 2
10/24/2002	WO2002083262A1 Cell separation compositions and methods
10/24/2002	WO2002083188A2 Dense/porous structures for use as bone substitutes
10/24/2002	WO2002083187A1 Systems and methods for inducing mixed chimerism
10/24/2002	WO2002083186A1 Nuclear receptor-mediated introduction of a pna into cell nuclei
10/24/2002	WO2002083179A2 Fusion proteins
10/24/2002	WO2002083160A2 Agents, which inhibit apoptosis in cells that are involved in wound healing
10/24/2002	WO2002083149A1 Drugs fo rpromoting the proliferation, differentiation and/or survival of glial cells containing cyclic phosphatidic acid
10/24/2002	WO2002083072A2 Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives
10/24/2002	WO2002083068A2 Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer
10/24/2002	WO2002083067A2 Prodrugs via acylation with cinnamate
10/24/2002	WO2002067665A3 Cloning of transgenic animals comprising artificial chromosomes
10/24/2002	WO2002064018A3 Immortalized human familial prostatic cancer cell lines
10/24/2002	WO2002060931A3 A fimbria-like gene in bifidobacteria
10/24/2002	WO2002056830A3 The use of immature dendritic cells to silence antigen specific cd8+t cell function
10/24/2002	WO2002045524A3 Prolyl endoprotease from aspergillus niger
10/24/2002	WO2002042419A3 Cell culture apparatus and methods of use
10/24/2002	WO2002032397A9 Electroprocessing in drug delivery and cell encapsulation
10/24/2002	WO2002031121A3 Improvement of endothelial cell-cell cohesion
10/24/2002	WO2002017935A3 A method of transplantation using chemotherapy-treated allogeneic cells that enhance immune responses without graft versus host disease
10/24/2002	WO2002006462A3 Methylated nucleotide regulation of upa gene expression
10/24/2002	WO2001073052A3 Thermophilic polymerase iii holoenzyme
10/24/2002	WO2001062793A9 Estrogen receptor beta variants and methods of detection thereof
10/24/2002	WO2001059103A9 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression
10/24/2002	WO2001059073A9 Cytotoxic t lymphocytes activated by dendritic cell hybrids
10/24/2002	WO2001058526A9 Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof
10/24/2002	WO2001055348A9 Improved inhibition of graft versus host disease
10/24/2002	WO2001055337A3 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides
10/24/2002	WO2001053465A9 Human embryoid body-derived cells
10/24/2002	WO1999050288A3 Mammalian blood loss-induced gene, kd312
10/24/2002	US20020157139 Soybean transformation method
10/24/2002	US20020157127 Transgene that comprises DNA encoding for epitope tagged TATA box binding protein (TBP), production of transgenic animals which express epitope-tagged TBP and use of epitope tagged TBP for isolating and affinity purifying transcription factors
10/24/2002	US20020157126 Transgenic nonhuman animal whose genome contains a nucleic acid sequence comprising a truncated Activin Type II receptor gene and a muscle-specific promoter operably linked and integrated into genome of animal; increased muscle mass
10/24/2002	US20020157124 Transgenic rodents and rodent cell lines expressing HIV co-receptors
10/24/2002	US20020157121 Propagation of human hepatocytes in non-human animals
10/24/2002	US20020156266 Sodium phosphate cotransporter expressed on apical surface of intestinal epithelial cells (huNpt2B) and polypeptides related thereto
10/24/2002	US20020156264 And method of using the carboxypeptidase polypeptides and polynucleotides as a target for diagnosis and treatment in carboxypeptidase-related disorders
10/24/2002	US20020156254 Nucleotide sequences coding polypeptide for use in the treatment of stress, diabetes, cancer, inflammatory and cardiovascular disorders
10/24/2002	US20020156252 Novel Stra6 polypeptides
10/24/2002	US20020156251 Fusion protein for use in the treatment and prevention of viral diseases
10/24/2002	US20020156246 15625 receptor, a novel G-protein coupled receptor
10/24/2002	US20020156244 Adipocyte complement related protein zacrp13
10/24/2002	US20020156243 Adipocyte-specific protein homologs
10/24/2002	US20020156049 Highly packed polycationic ammonium, sulfonium and phosphonium lipids
10/24/2002	US20020156042 Human suppressor tRNA oligonucleotides and methods of use for same
10/24/2002	US20020156034 Chemokine receptor antagonists, including peptide antagonists of CXC chemokine receptor 4 (CXCR4) for use in the treatment of hematopoietic (stem/progenitor) cells; mobilize the these cells from marrow to peripheral blood; gene therapy
10/24/2002	US20020156031 A DNA segment comprising a protein coding region encoding an Osterix polypeptide; gene therapy; osteoporosis; recombinant Osterix polypeptide
10/24/2002	US20020156007 Apolipoprotein analogues
10/24/2002	US20020156006 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/24/2002	US20020156004 Polypeptides having significant homology to the prolactin receptor protein
10/24/2002	US20020156001 Novel fibroblast growth factor ( FGF23) and methods for use
10/24/2002	US20020155998 Erythropoietin analog-human serum albumin fusion
10/24/2002	US20020155997 Biologically active material isolated from non-pathogenic bacteria, such as Enterobacteriaceae
10/24/2002	US20020155987 Isolated endostatin, especially approximately 20 kDa and corresponds to a C-terminal fragment of collagen type XVIII
10/24/2002	US20020155610 High-efficiency wild-type-free AAV helper functions
10/24/2002	US20020155608 Methods for delivering DNA to muscle cells using recombinant adeno-associated virus virions
10/24/2002	US20020155605 Expression vector for use as tool in controlling gene expression in plants
10/24/2002	US20020155604 Compositions and methods for regulating lymphocyte activation
10/24/2002	US20020155603 Cell culture media for mammalian cells
10/24/2002	US20020155602 Vectors, cells and methods for the production of deleterious viral eukaryotic gene transfer vectors
10/24/2002	US20020155601 Method for producing a population of homozygous stem cells having a pre-selected immunotype and/or genotype, cells suitable for transplant derived therefrom, and materials and methods using same
10/24/2002	US20020155599 Separating and recovering cells, proteins or other particles using electromagnetic fields; obtain sample insert into container, activate magnet, vary field strengths, separate and recover particles
10/24/2002	US20020155598 Generating insulin secreting cells; obtain mammalian pancreatic tissues, dissociate cells, dedifferentiate into insulin precursor cells, isolate and propagate cells
10/24/2002	US20020155597 In vivo production and delivery of erthropoietin or insulinotropin for gene therapy
10/24/2002	US20020155595 Intermittent immersion vessel apparatus and process for plant propagation
10/24/2002	US20020155577 Compound for use in the treatment of parkinson's disease
10/24/2002	US20020155573 Cod uracil-DNA glycosylase, gene coding therefore, recombinant DNA containing said gene or operative parts thereof, a method for preparing said protein and the use of said protein or said operative parts thereof in monitoring or controlling PCR
10/24/2002	US20020155572 Peptide for use in diagnosis and treatment of alzheimier's disease
10/24/2002	US20020155559 Solid support for the generaton and propagation of preferential tissues
10/24/2002	US20020155547 Polypeptide for use in the treatment of cancer, hepatitis, multiple sclerosis, fibrosis, inflammatory or autoimmune diseases, cancers and viral diseases
10/24/2002	US20020155545 Chemokines expressed in pancreas
10/24/2002	US20020155543 Fibroblast growth factor-19 (FGF-19) nucleic acids and polypeptides and methods of use for the treatment of obesity and related disorders
10/24/2002	US20020155539 Calcium channel polynucleotides, polypeptides, and antibodies
10/24/2002	US20020155537 Method for making heteromultimeric polypeptides
10/24/2002	US20020155531 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
10/24/2002	US20020155528 Regulation of human CysLT2-like GPCR protein
10/24/2002	US20020155525 Expression vector for use in generation of preferential polypeptides in culture
10/24/2002	US20020155520 Coating particle with dye; contacting cell; releasing dye
10/24/2002	US20020155511 Novel antibody compositions for the negative selection of specific rat leukocyte subsets
10/24/2002	US20020155510 Dendritic cell-specific antibodies
10/24/2002	US20020155507 Cells having a spectral signature, and methods of preparation and use thereof
10/24/2002	US20020155498 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof
10/24/2002	US20020155487 Method and apparatus for holding cells
10/24/2002	US20020155471 Compounds for therapy and diagnosis and methods for using same
10/24/2002	US20020155454 Miniribozymes active at low magnesium ion concentrations
10/24/2002	US20020155453 Method for generating diversity
10/24/2002	US20020155447 Nucleotide sequences coding polypeptide for use in the treatment of cancer
10/24/2002	US20020155434 Fusion protein for use in the treatment of viral diseases
10/24/2002	US20020155433 Polypeptide for use the prevention of infections associated with tissue grafting
10/24/2002	US20020155428 Retrovirus from the HIV group and its use
10/24/2002	US20020155423 Method of concentrating and separating dopaminergic neurons
10/24/2002	US20020155178 Compositions and methods for cancer prevention and treatment derived from Inula britannica

1 ... 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 ... 1827